April 23, 2020 / 11:45 PM / a month ago

BRIEF-Botanix Pharmaceuticals Says FDA Grants Btx 1801 Qualified Infectious Disease Product Designation Status

April 24 (Reuters) - Botanix Pharmaceuticals Ltd:

* BOTANIX PHARMACEUTICALS-FDA GRANTS BTX 1801 QUALIFIED INFECTIOUS DISEASE PRODUCT DESIGNATION STATUS Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below